Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aliza Thompson

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical Journal of the American Society of Nephrology : CJASN|January 13, 2019
Proteinuria Reduction as a Surrogate End Point in Trials of IgA NephropathyAliza Thompson, Kevin Carroll, Lesley A Inker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2024
Proteinuria as an End Point in Clinical Trials of Focal Segmental GlomerulosclerosisLaura H Mariani, Howard Trachtman, Aliza Thompson, et al.
Kidney International|September 26, 2025
Strategies for the development of sodium-glucose cotransporter-2 inhibitors for kidney protection in pediatric chronic kidney disease: proceedings of a workshop meeting in July 2023William E Smoyer, Barbara S Gillespie, Louise Oni, et al.
Kidney International|October 27, 2018
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshopAllison Tong, Braden Manns, Angela Yee Moon Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work GroupCarla Nester, Dima A Decker, Matthias Meier, et al.
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
Nature Biotechnology|May 12, 2010
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing ConsortiumFrank Dieterle, Frank Sistare, Federico Goodsaid, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Journal of the American Society of Nephrology : CJASN|January 13, 2019
Proteinuria Reduction as a Surrogate End Point in Trials of IgA NephropathyAliza Thompson, Kevin Carroll, Lesley A Inker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2024
Proteinuria as an End Point in Clinical Trials of Focal Segmental GlomerulosclerosisLaura H Mariani, Howard Trachtman, Aliza Thompson, et al.
Kidney International|September 26, 2025
Strategies for the development of sodium-glucose cotransporter-2 inhibitors for kidney protection in pediatric chronic kidney disease: proceedings of a workshop meeting in July 2023William E Smoyer, Barbara S Gillespie, Louise Oni, et al.
Kidney International|October 27, 2018
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshopAllison Tong, Braden Manns, Angela Yee Moon Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work GroupCarla Nester, Dima A Decker, Matthias Meier, et al.
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
Nature Biotechnology|May 12, 2010
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing ConsortiumFrank Dieterle, Frank Sistare, Federico Goodsaid, et al.
Pageof 3